Linker Information

General Information of This Linker
Linker ID
LIN0WYMQF
Linker Name
Cys-13 ADC linker
Linker Type
Thiol-sensitive linker
Antibody-Linker Relation
Cleavable
Structure
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
XMT-1592 [Phase 1/2]
 ADC Info 
Identified from the Human Clinical Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Related Clinical Trial
NCT Number NCT04396340  Clinical Status Phase 1/2
Clinical Description
A phase 1b, first-in-human, dose escalation and expansion study of XMT-1592 in patients with solid tumors likely to express NAPI2B.
References
Ref 1 A Phase 1b, First-in-Human, Dose Escalation and Expansion Study of XMT-1592 In Patients With Solid Tumors Likely to Express NaPi2b, NCT04396340

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.